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Abstract: 
11C-labeled carbamates can be obtained in a three-component coupling reaction of primary or secondary amines 
with CO2 and 
11C-methylation reagents. [
11C]Methyl-triflate mediated methylation of carbamino adducts provides the cor-
responding 
11C-labeled carbamate groups in excellent yields under mild conditions (temperatures  40°C, 2 min reaction 
time). The utility of the method has been demonstrated by a highly efficient radiosynthesis of [
11C]GR103545. 
INTRODUCTION 
 In  vivo quantification of opioid receptors (ORs) and 
changes in their distribution and availability in the central 
nervous system (CNS) following neurodegenerative dis-
eases, substance abuse and nociceptive signaling is crucial 
for precise diagnosis and therapy monitoring (for review see: 
Henriksen and Willoch, 2008 [1]). Three well-defined sub-
types of cerebral ORs with different functional properties are 
known: μ-,- and -OR (Knapp et al., 1995) [2], Connor and 
Christie, 1999) [3]. A number of tracers have been devel-
oped for imaging of opioid receptors with positron emission 
tomography (PET) (Henriksen and Willoch) [1], Henriksen 
et al., 2006 [4], however only the -OR-selective  [
11C-
methyl]naltrindole and the μ-OR-selective  [
11C]carfentanil 
depict single subclasses of the ORs in humans. 
  11C-labeled carbamate (-)-4-methoxycarbonyl-2-[(1-pyr-
rolidinylmethyl]-1-[(3,4-dichlorophenyl)acetyl-piperidine ([
11C] 
GR103545) is a promising PET tracer for imaging of the -
OR. Dynamic studies with [
11C]GR103545 in baboons dem-
onstrated high -OR affinity, excellent brain penetration, 
rapid uptake and wash-out kinetics, and low degree of non-
specific binding (Talbot et al., 2005 [5]). 
  The reported radiosynthesis of [
11C]GR103545 relies on 
reduction of cyclotron produced [
11C]carbon dioxide to form 
[
11C]methanol, treatment with phosgene to produce   
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[
11C]methyl chloroformate, and subsequent reaction with the 
amine precursor to provide the 
11C-labeled carbamate group 
(Ravert et al., 1999 [6]; (Ravert et al., 2002) [7]. Unfortu-
nately, the method provides low radiochemical yields (RCY) 
in the range of 2 (Talbot et al. 2005) to 14% (Ravert et al., 
2002) [7]. Together with the large variations in the specific 
activity obtained (2564 mCi/μmol (Ravert et al., 2002) [7], 
150-495 mCi/μmol (Talbot et al. 2005 [5]), it is indicated 
that this method is capricious and thus effectively preventing 
human studies with [
11C]GR103545. 
  Here we report a new method for radiosynthesis of 
11C-
carbamate groups based on in situ reaction of amines with 
carbon dioxide and subsequent 
11C-methylation of the car-
bamino adduct. As the method only requires a single radio-
active step, the entire process of labeling, purification and 
product formulation can readily be carried out using an 
automated synthesis module. 
  In the initial part of the study, the carbamation of benzy-
lamine 1 was formed by reaction with CO2 in the presence of 
Cs2CO3 and tetrabutyl ammonium iodide (TBAI). 
11C-
Methylation with [
11C]CH3I under conditions similar to those 
reported for formation of non-radioactive carbamates (Salva-
tore et al., 2001 [8]) provided carbamate 2 (Table 1) in 18-
36% radiochemical yield (RCY) [9]. Attempts to improve the 
radiochemical yield by heating the reaction mixture resulted in 
formation of N-[
11C-methyl]benzylamine (3) [10] in addition 
to the desired [
11C]carbamate 2. The reduced chemoselectivity 
of the reaction at elevated temperature may be due to decom-
position of the carbamino adduct and subsequent N-alkylation 
of the free amine as outlined in Scheme 1. Synthesis of 
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Scheme 1. Reaction of benzylamine with CO2 to form the car-
bamino adduct and alkylation with [
11C]CH3I. 
Table 1.  Radiochemical Yield
a of N-benzyl-[
11C]methyl Car-
bamate (2)
b,c 
 
Phase-Transfer  
Catalyst 
Methylation  
Agent 
T 
(°C) 
Reaction Time  
(min)  RCY
a 
TBAI  [
11C]MeI  25  5  36 ± 7 
TBAI  [
11C]MeI  40  5  27 ± 6 
TBAI  [
11C]MeI  50  5  21 ± 3 
TBAI  [
11C]MeI  70  5  18 ± 4 
TBAOTf  [
11C]MeOTf  25  2  69 ± 8 
TBAOTf  [
11C]MeOTf  25  5  78 ± 6 
TBAOTf  [
11C]MeOTf  35  2  82 ± 4 
TBAOTf  [
11C]MeOTf  40  2  91 ± 5 
aDetermined by analytical radio-HPLC 
bResults represent the mean ± sd, n = 4. 
cTo a solution of benzylamine (1) (2 mg, 18.6 μmol) in anhydrous DMF (500 μl) was 
added 3 molar equivalents of the TBA-reagent and 3 molar equivalents of Cs2CO3. CO2 
gas (20 ml/min) was bubbled through the suspension for 1 h at room temperature. The 
11C-alkylating agent was swept trapped in the reaction vial and allowed to react for the 
desired period of time. 
 
  Because of the apparent instability of the carbamino ad-
duct at higher temperature, methylation with the more reac-
tive [
11C]methyl-triflate ([
11C]CH3OTf) [11] was evaluated. 
Initial experiments with [
11C]CH3OTf were performed under 
identical conditions to those used for alkylation with 
[
11C]CH3I. Also in these experiments, the N-methylated side 
product 3 was observed when the reaction was carried out at 
elevated temperatures. We speculated that the large excess of 
iodide in the reaction mixture, resulting from addition of 
TBAI, may react with [
11C]CH3OTf to form [
11C]CH3I  in 
situ. Substituting the phase-transfer catalyst with tetrabutyl 
ammonium triflate (TBAOTf) resulted in RCYs in the range 
of 69 ± 8 to 91 ± 5% within 2 min at 25 and 40°C, respec-
tively (Table 1). Notably, even at 40°C the reaction provided 
the [
11C]carbamate  2  exclusively with  no formation of N-
[
11C-methyl]-benzylamine (3). Thus, the results suggest that 
the high reactivity of [
11C]CH3OTf enables alkylation to pro-
ceed to completion prior to decomposition of the carbamino 
adduct. 
Table 2.  Radiochemical Yield
a of [
11C]GR103454
b,c 
 
   
HN N
Cl
Cl N
O
NN
Cl
Cl N
H3
11CO
O O
 
T (°C)  Reaction Time (min)  RCY
a 
25  5  64 ± 5 
35  5  72 ± 6 
40  2  84 ± 4 
40  5  91 ± 5 
aDetermined by analytical radio-HPLC 
b Results represent the mean ± std, n = 5. 
c To a solution of des-carbamate-GR103545 (3 mg, 8.4 μmol) in anhydrous DMF (500 
μl) was added 3 molar equivalents of the TBA-reagent and 3 molar equivalents of 
Cs2CO3. CO2 gas (20 ml/min) was bubbled through the suspension for 1 h at room 
temperature. Subsequently, the 
11C-alkylating agent was swept trapped in the reaction 
vial and allowed to react for the desired period of time. 
 
  Using the optimized conditions for 
11C-carbamate forma-
tion,  des-carbamate-GR103545  [12] was converted to 
[
11C]GR103545 in up to 91 ± 5% RCY (Table 2). The car-
bamino adduct solution in DMF was found to effectively 
trap [
11C]CH3OTf, with a volume of 100 μl sufficient to re-
tain > 90% of the total activity introduced. Using the reduced 
volume (100 μl) of the precursor solution in preparative runs 
[13],  [
11C]GR103545 was obtained in 85 ± 6% isolated 
RCY, with a specific activity of 1792 ± 312 mCi/μmol and 
radiochemical purity of > 98%. The total synthesis time, 
including purification and formulation, was < 25 min after 
end-of-bombardment (n = 8). The short synthesis time, high 
specific activity and excellent RCY achieved with this 
method should facilitate evaluation of the -OR tracer 
[
11C]GR103545 in clinical trials. 
CONCLUSION 
  [
11C]MeOTf has been shown to rapidly methylate car-
bamino adducts of primary and secondary amines, providing 
the corresponding 
11C-carbamate groups in excellent yields 
under mild conditions (temperatures  40°C, 2 min reaction 
time). The utility of the method has been demonstrated by a 
highly efficient radiosynthesis of [
11C]GR103545. The 
method is suitable for automated routine production using 
synthesis modules compatible with good manufacturing 
practice. 
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